medigraphic.com
ISSN 1561-3062 (Electronic)

2020, Number 1

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2020; 46 (1)

Rh incompatibility and isoimmunization in pregnant women

Zapata-Cardona LM, Martínez Sanchez LM, Jaramillo-Jaramillo LI

Language: Spanish
References: 25
Page: 1-13
PDF size: 277.45 Kb.


ABSTRACT

Isoimmunization is a condition that occurs when there is Rh incompatibility between mothers and their fetus; epidemiology and ethnicity are relevant variables in this entity. The risk that it poses mainly to the fetus and the newborn is important, since it can trigger severe fetal anemia and hydrops fetalis leading to death. This article is a concise bibliographic review ranging from the basic aspects such as epidemiology and pathophysiology, to the behavior to follow with a pregnant woman diagnosed with this condition, or the risk of developing it. Our objective is to offer healthcare professionals a concise overview of Rh incompatibility and isoimmunization and the more complex details of diagnosis and its medical performance.


REFERENCES

  1. Vizueta CA, López BO, Balon JE, Zambrano RH. Incompatibilidad Rh en el embarazo. Dom Cien. 2017;3(4):32-46. DOI: 10.23857/10.23857/dom.cien.pocaip.2017.3.4.oct.32-46.

  2. De Haas M, Thurik FF, van der Ploeg C, Veldhuisen B, Hirschberg H, et al. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programmer in the Netherlands. BMJ 2016; 355:i5789. DOI: 10.1136/bmj.i5789.

  3. Management of Alloimmunization During Pregnancy. Practice Bulletin No. 192. American College of Obstetricians and Gynecologist. 2018;131(3):e82-90. DOI: 1097/AOG.0000000000002525.

  4. Omeñaca F, de la Camara C, Valverde E. Enfermedad hemolítica del recién nacido. En: Asociación Española de Pediatría. Protocolos Diagnóstico Terapeúticos de la AEP. Neonatología. [Internet]. 2008 [citado 04/02/2019];384-8. Disponible en: https://www.aeped.es/sites/default/files/documentos/39.pdf.

  5. Lambertino JR, Villegas SM. Aloinmunización Rh en mujeres gestantes, una mirada al diagnóstico y a su aproximación terapéutica. Ginecol Obstet Mex. [Internet]. 2014 [citado 04/02/2019];82(11):744-54. Disponible en: https://ginecologiayobstetricia.org.mx/secciones/articulos-de-revision/aloinmunizacion-rh-en-mujeres-gestantes-una-mirada-al-diagnostico-y-a-su-aproximacion-terapeutica/

  6. Abbey R, Dunsmoor-Su R. Cost–Benefit Analysis of Indirect Antiglobulin Screening in Rh(D)-Negative Women at 28 Weeks of Gestation. Obstet Gynecol. 2014;123:938–45. DOI: 10.1097/AOG.0000000000000224.

  7. Fuenzalida J, Carvajal JA. Manejo de la embarazada con isoinmunización por anticuerpos irregulares. Rev Chil Obstet Ginecol. 2014;79(4):315–22. DOI: 10.4067/S0717-75262014000400011.

  8. Andersson L, Szabo F. The incidence and outcome of clinically significant antibodies detected in Rhesus-D positive pregnant women of the Northern Territory. Aust N Z J Obstet Gynaecol. 2017; 58(5):514-517. DOI: 10.1111/ajo.12750.

  9. Molina S, Moise KJ. Aloinmunización Rh: manejo anteparto. Revisión de la literatura. Rev Col Obst Ginec [Internet]. 2009 [citado 04/02/2019];60(3):262-73. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/331.

  10. Turner RM, Lloyd-Jones M, Anumba D, Smith G, Spiegelhalter D, Squires H, et al. Routine Antenatal Anti-D Prophylaxis in Women Who Are Rh(D) Negative: Meta-Analyses Adjusted for Differences in Study Design and Quality. PLoS ONE 2012;7(2):e30711. DOI: 10.1371/journal.pone.0030711.

  11. Prevention of Rh D Alloimmunization. Practice Bulletin No. 181. American College of Obstetricians and Gynecologist. 2017;130(2):e57-70. DOI: 10.1097/AOG.0000000000002232.

  12. Guía Clínica: Isoinmunización. Guias Clínicas Medicina Materno-Fetal. Servei D’obstetricia – Icgon – Hospital Clínic Barcelona. [Internet] 2014. [citado 10/02/2019]. Disponible en: https://medicinafetalbarcelona.org/protocolos/es/patologia-fetal/isoinmunizacion-y-transfusion-intrauterina.html.

  13. Arias A. Isoinmunización Rh (descripción de un caso). Rev Med Costa Rica Centroam. 2008;LXV(583):163-8. DOI: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2008/rmc082p.pdf.

  14. Neal JL. RhD Isoimmunization and Current Management Modalities. JOGNN 2001;30(6):589-606. DOI: 0.1111/j.1552-6909.2001.tb00006.x.

  15. RCOG Green-top Guideline No. 65. Royal College of Obstetricians and Gynaecologists. [Internet] 2014. [citado 04/02/2019]. Disponible en: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg65.

  16. Rosenbloom JI, Bruno AM, Conner SN, et al. Fetal thrombocytopenia in pregnancies complicated by fetal anemia due to red-cell alloimmunization: cohort study and meta-analysis. J Perinatol. 2019;39:920. DOI: 10.1038/s41372-019-0388-8.

  17. Moise KJ Jr. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol. 2008;198:161:e-4. DOI: 10.1016/j.ajog.2007.10.788.

  18. Mari G. Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: the untold story. Ultrasound Obstet Gynecol. 2005;25(4):323-30. DOI: 10.1002/uog.1882.

  19. Fyfe TM, Ritchey MJ, Taruc C, Crompton D, Galliford B, Perrin R. Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review. Pregnancy and Childbirth. 2014;14(411):1-6. DOI: 10.1186/s12884-014-0411-1.

  20. McBain RD, Crowther CA, Middleton P. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation (Review). Cochrane Database of Systematic Reviews. 2015;9:CD000020. DOI: 10.1002/14651858. CD000020.pub3.

  21. Lubusky M, Simetka O, Studnickova M, Prochazka M, Ordeltova M, Vomackova K. Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section. Transfusion. 2012;52(9):1977-82. DOI: 10.1111/j.1537-2995.2011.03536.x.

  22. Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014;24:8–20. DOI: 10.1111/tme.12091.

  23. Kumpel BM. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Transfusion. 2006;46:1652. DOI: 10.1111/j.1537-2995.2006.00924_1.x.

  24. Moise KJ Jr, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol. 2012;120:1132. DOI: 10.1097/AOG.0b013e31826d7dc1.

  25. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: The fetus at risk for anemia-diagnosis and management. Am J Obstet Gynecol. 2015;697-710. DOI: 10.1016/j.ajog.2015.01.059.




2020     |     www.medigraphic.com